Phase I trial of a cancer vaccine consisting of 20 mixed peptides in patients with castration-resistant prostate cancer: dose-related immune boosting and suppression-Reference-Cited by-同舟云学术

Phase I trial of a cancer vaccine consisting of 20 mixed peptides in patients with castration-resistant prostate cancer: dose-related immune boosting and suppression

Published:2015-02-07 Issue:4 Volume:64 Page:493-505
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Noguchi Masanori,Arai Gaku,Matsumoto Kazumasa,Naito Seiji,Moriya Fukuko,Suekane Shigetaka,Komatsu Nobukazu,Matsueda Satoko,Sasada Tetsuro,Yamada Akira,Kakuma Tatsuyuki,Itoh Kyogo

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-015-1660-1.pdf

Reference30 articles.

1. Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL, Restifo NP, Dudley ME, Schwarz SL, Spiess PJ, Wunderlich JR, Parkhurst MR, Kawakami Y, Seipp CA, Einhorn JH, White DE (1998) Immunologic and therapeutic evaluation of synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat Med 4:321–327

2. Schwartzentruber DJ, Lawson DH, Richards JM, Conry RM, Miller DM, Treisman J, Gailani F, Riley L, Conlon K, Pockaj B, Kendra KL, White RL, Gonzalez R, Kuzel TM, Curti B, Leming PD, Whitman ED, Balkissoon J, Reintgen DS, Kaufman H, Marincola FM, Merino MJ, Rosenberg SA, Choyke P, Vena D, Hwu P (2011) gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma. N Engl J Med 364:2119–2127

3. Perez SA, Hofe E, Kallinteris NL, Gritzapis AD, Peoples GE, Papamichail M, Baxevanis C (2010) A new era in anticancer peptide vaccines. Cancer 116:2071–2080

4. Cheever MA, Allison JP, Ferris AS, Finn OJ, Hastings BM, Hecht TT, Mellman I, Prindiville SA, Viner JL, Weiner LM, Matrisian LM (2009) The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research. Clin Cancer Res 15:5323–5337

5. Sasada T, Komatsu N, Suekane S, Yamada A, Noguchi M, Itoh K (2010) Overcoming the hurdles of randomized clinical trials of therapeutic cancer vaccine. Eur J Cancer 46:1514–1519

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemical Strategies towards the Development of Effective Anticancer Peptides;Current Medicinal Chemistry;2024-04

2. TAS0313 plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint Inhibitor—Naïve Locally Advanced or Metastatic Urothelial Carcinoma;Molecular Cancer Therapeutics;2024-01-11

3. Potential of Personalized Dendritic Cell-Based Immunohybridoma Vaccines to Treat Prostate Cancer;Life;2023-07-01

4. Cancer Vaccines for Triple-Negative Breast Cancer: A Systematic Review;Vaccines;2023-01-09

5. In Silico Model Estimates the Clinical Trial Outcome of Cancer Vaccines;Cells;2021-11-05